MYX Declaration of Unacceptable Circumstances and Orders
Filed with ASX · · 11 pages · English
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings CallThe Panel has made a declaration of unacceptable circumstances (Annexure A) in relation to an application dated 6 November 2025 by Mayne Pharma Group Limited in relation to its own affairs (see TP25/093 and TP25/095). The Panel has also made final orders (Annexure B) including orders requiring Cosette Pharmaceuticals, Inc. to agree to any conditions reasonably required by the Treasurer (in relatio
Mayne Pharma Group Ltd. on 6ix
Story so far
Earlier from Mayne Pharma
- Update on FIRB approval and Scheme
- MYX - Panel Conducts Proceedings and Makes Interim Orders
- Update on Scheme and Supreme Court of NSW proceedings
- MYX Scheme of Arrangement update on FIRB approval
- Outcome of litigation and update on Scheme
Later from Mayne Pharma
- Update on status of FIRB approval and second court hearing
- Pause in Trading
- Trading Halt
- Update on FIRB condition and scheme
- Mayne Pharma issues notice of intention to terminate the SID
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma